A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to measure the safety, preliminary antitumor activity, pharmacokinetics, and pharmacodynamics with BGB-16673 in combination with other agents in participants with relapsed or refractory (R/R) B-cell malignancies. This study is structured as a master protocol with separate substudies. This study currently includes four substudies, and more substudies may be added as other combination agents are identified.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza nawrotowego lub opornego na leczenie chłoniaka z komórek B
- •Choroba mierzalna i widoczna w badaniach
- •Zdolność samodzielnego funkcjonowania (stan ogólny 0-2)
- •Prawidłowe funkcjonowanie narządów wewnętrznych
- •Kobiety mogące mieć dzieci muszą stosować skuteczną antykoncepcję przez cały czas badania i przez określony czas po leczeniu
- •Mężczyźni muszą stosować skuteczną antykoncepcję przez cały czas badania i przez określony czas po leczeniu
- •Wystarczająca funkcja nerek (dla niektórych grup badawczych eGFR ≥50, dla innych ≥30 mL/min)
- •Niemożliwość zajścia w ciążę potwierdzona testem przed rozpoczęciem badania
✗ Disqualifies
- •Pacjenci, którzy wcześniej nie otrzymywali leczenia z powodu chłoniaka
- •Niezdolność do przestrzegania wymogów badania
- •Aktywna choroba w oponach mózgowych lub nieuprawnione przerzuty do mózgu
- •Inny nowotwór zdiagnozowany w ciągu ostatnich 2 lat (z wyjątkiem badanego chłoniaka)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (50)
Mayo Clinic Phoenix
Phoenix, United States
University of Southern California Norris Comprehensive
Los Angeles, United States
Mayo Clinic Jacksonville
Jacksonville, United States
Moffitt Cancer Center
Tampa, United States
The University of Kansas Cancer Center
Westwood, United States
Mayo Clinic Rochester
Rochester, United States
Washington University School of Medicine
St Louis, United States
Summit Medical Group
Florham Park, United States
Icahn School of Medicine At Mount Sinai
New York, United States
Columbia University Medical Center
New York, United States
Weill Cornell Medical College Newyork Presbyterian Hospital
New York, United States
Memorial Sloan Kettering Cancer Center Mskcc
New York, United States
University of Rochester
Rochester, United States
Fox Chase Cancer Center
Philadelphia, United States
The University of Texas Md Anderson Cancer Center
Houston, United States
Huntsman Cancer Institute
Salt Lake City, United States
University of Wisconsin
Madison, United States
Medical College of Wisconsin
Milwaukee, United States
St George Hospital
Kogarah, Australia
Mater Cancer Care Centre
South Brisbane, Australia
Monash Health
Clayton, Australia
Peter Maccallum Cancer Centre
Melbourne, Australia
The Alfred Hospital
Melbourne, Australia
Linear Clinical Research
Nedlands, Australia
Hospital Sirio Libanes Brasilia
Brasília, Brazil
Ensino E Terapia de Inovacao Clinica Amo Etica
Salvador, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto
São José do Rio Preto, Brazil
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, Brazil
Fujian Medical University Union Hospital
Fuzhou, China
Sun Yat Sen University Cancer Center
Guangzhou, China
The First Affiliated Hospital of Soochow University
Suzhou, China
The First Affiliated Hospital, Zhejiang University School of Medicinechengzhan
Hangzhou, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden
Dresden, Germany
Universitatsklinikum Jena Klinik Fur Innere Medizin Ii
Jena, Germany
Universitatsklinikum Schleswig Holstein Campus Kiel
Kiel, Germany
Medizinische Universitaetsklinik
Tübingen, Germany
Universitaetsklinikum Ulm
Ulm, Germany
Azienda Ospedaliera Universitaria Policlinico Santorsola Malpighi
Bologna, Italy
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, Italy
Istituto Nazionale Tumori Fondazione G Pascale
Naples, Italy
Istituto Clinico Humanitas
Rozzano, Italy
Centroricerche Cliniche Di Verona Srl
Verona, Italy
North Shore Hospital
Auckland, New Zealand
Auckland City Hospital
Auckland, New Zealand
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie
Lublin, Poland
Szpital Kliniczny Mswia Z Warmisko Mazurskim Centrum Onkologii
Olsztyn, Poland
Szpital Wojewodzki W Opolu Sp Z Oo Oddzia Hematologii I Onkologii Hematologicznej
Opole, Poland
Narodowy Instytut Onkologii Im Marii Sklodowskiej Curie W Warszawie
Warsaw, Poland
Trial contact
Study Director
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.